Voice your opinion on congressional bill HR133-118 and let lawmakers know your stance with UnPac!

Main Subject: Health

Mandating Exclusive Review of Individual Treatments (MERIT) Act

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.

House committee actions Actions

Committee
Dec. 06 2023	Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0. Committee Consideration and Mark-up Session Held
Dec. 05 2023	Committee Consideration and Mark-up Session Held
Nov. 15 2023	Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote. Subcommittee Consideration and Mark-up Session Held
Jan. 20 2023	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Jan. 09
2023

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Jan. 09 2023	Introduced in House Introduced in House

House bill HR133-118

Mandating Exclusive Review of Individual Treatments (MERIT) Act

Promote the cause!

Or use this QR code